Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion type Assertion NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_head.
- NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion description "[In prostate cancer the secreted form of clusterin (sCLU) has been described as an anti-apoptotic protein whose expression is increased after therapeutic intervention, whereas, the nuclear protein form nCLU was reported to have pro-apoptotic properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_provenance.
- NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion evidence source_evidence_literature NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_provenance.
- NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion SIO_000772 23418433 NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_provenance.
- NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion wasDerivedFrom befree-20140225 NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_provenance.
- NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_assertion wasGeneratedBy ECO_0000203 NP770050.RA7yBMSg8OPAGEUxY0rUcgQTYN5TlINkC9PII2tTloGk4130_provenance.